Department of Pharmacy, University of Salerno, Fisciano, 84084, Italy.
Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi, 84081, Italy.
Int J Nanomedicine. 2024 Sep 11;19:9373-9393. doi: 10.2147/IJN.S479959. eCollection 2024.
Extracellular vesicles (EVs) are promising tools for nanomedicine and nanobiotechnology. The purification of mammalian-derived EVs involves intensive processes, and their therapeutic application raises multiple safety and regulatory issues. Plants have the potential to serve as nonconventional sources of therapeutically relevant EVs. In this context, we recently identified hairy roots (HRs) of medicinal plants as a novel biotechnological platform to produce EVs for human health.
Herein, we report the purification, omics profiling, and bioactivity of EVs isolated from HRs of the medicinal plants and . EVs were isolated from conditioned media of HR cultures using differential ultracentrifugation (dUC) and size exclusion chromatography (SEC). The isolated EVs were characterized by nanoparticle tracking analysis (NTA) and electron microscopy. The proteomic and metabolomic profiles of the EVs were determined using mass spectrometry. Uptake studies and bioactivity assays, including confocal microscopy, MTT, flow cytometry, ROS quantification, and untargeted metabolomics analyses, were conducted in SH-SY5Y cells treated with the neurotoxin 6-hydroxydopamine (6-OHDA) to evaluate the therapeutic potential of EVs in an in vitro model of Parkinson's disease.
HRs released nanosized round-shaped EVs with a distinctive molecular signature. HR EVs from and revealed conserved cargo of secondary metabolites, predominantly triterpenoids, which are known for their antioxidant properties. We showed that HR EVs are safe, enter the cells, and strongly inhibit apoptosis in a cellular model of Parkinson's disease. Cellular metabolomics revealed that EVs preserved metabolic homeostasis and mitigated cellular oxidative stress when co-administered with 6-OHDA. Mechanistically, HR EVs inhibited 6-OHDA autoxidation and substantially reduced the accumulation of its oxidative products, which are responsible for 6-OHDA-induced toxicity.
Collectively, our findings provide compelling evidence that EVs isolated from the hairy roots of pecies are promising, non-mammalian alternative for the design of novel therapies targeting neurological disorders.
细胞外囊泡(EVs)是纳米医学和纳米生物技术有前途的工具。哺乳动物来源的 EVs 的纯化涉及密集的过程,其治疗应用引发了多个安全和监管问题。植物有可能成为治疗相关 EVs 的非常规来源。在这种情况下,我们最近发现药用植物的发根(HRs)是一种生产用于人类健康的 EVs 的新型生物技术平台。
本文报道了从药用植物和中分离的 HRs 中分离的 EVs 的纯化、组学分析和生物活性。使用差速超速离心(dUC)和分子筛层析(SEC)从 HR 培养物的条件培养基中分离 EVs。通过纳米颗粒跟踪分析(NTA)和电子显微镜对分离的 EVs 进行了表征。使用质谱法确定 EVs 的蛋白质组学和代谢组学图谱。通过共聚焦显微镜、MTT、流式细胞术、ROS 定量和非靶向代谢组学分析,在接受神经毒素 6-羟多巴胺(6-OHDA)处理的 SH-SY5Y 细胞中进行摄取研究和生物活性测定,以评估 EVs 在帕金森病体外模型中的治疗潜力。
HRs 释放出具有独特分子特征的纳米尺寸圆形 EVs。和的 HR EVs 显示出次生代谢物的保守货物,主要是三萜类化合物,它们以其抗氧化特性而闻名。我们表明,HR EVs 是安全的,进入细胞,并在帕金森病的细胞模型中强烈抑制细胞凋亡。细胞代谢组学显示,EVs 保持代谢平衡并减轻细胞氧化应激,同时与 6-OHDA 联合给药。从机制上讲,HR EVs 抑制 6-OHDA 自氧化,并大大减少其氧化产物的积累,这些产物是 6-OHDA 诱导毒性的原因。
总的来说,我们的研究结果提供了令人信服的证据,表明从种属的发根中分离的 EVs 是有前途的非哺乳动物替代物,可用于设计针对神经疾病的新型治疗方法。